Acessa Health plans to develop new products and expand its market reach.

It’s been a whirlwind few months for medical device maker Acessa Health.

In June, the company announced it had acquired a noninvasive treatment for uterine fibroids from a California medical device company.

At the same time, the company said it had secured $30 million in Series A financing to expand its product portfolio, develop new technology and expand sales and marketing.

[Continue reading article on]